Infection with nontuberculous mycobacteria is one of the most feared and poorly understood complications of CF lung disease. There is a good deal of uncertainty in identifying which patients will benefit from treatment, which antibiotics to use, proper dosing and monitoring, specific aspects of respiratory care, and how long to continue treatment. This Symposium will review the central aspects of the diagnosis and treatment of NTM in individuals with CF, based on the 2016 CFF/ECFC Guidelines. In particular, the role and coordination of the multidisciplinary team will be emphasized.
Review the criteria for treatment of NTM in the context of CF lung disease.
Discuss the considerations for the selection and administration of antibiotics for the treatment of NTM disease.
Describe specific consideration for airway clearance, respiratory therapy and coordination of the multidisciplinary team in optimizing response to NTM treatment.